Skip to Content

Plasma protein fraction Pregnancy and Breastfeeding Warnings

Plasma protein fraction is also known as: Octaplas, Plasma-Plex, Plasmanate, Plasmatein, Protenate

Plasma protein fraction Pregnancy Warnings

Animal studies have not been conducted.

There are no controlled data in human pregnancy.

FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

FDA pregnancy category: C

Use plasma protein fraction only if clearly needed.

See references

Plasma protein fraction Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Plasmanate (plasma protein fraction)." Bayer Pharmaceutical Inc, West Haven, CT.

References for breastfeeding information

  1. "Product Information. Plasmanate (plasma protein fraction)." Bayer Pharmaceutical Inc, West Haven, CT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide